Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency

被引:26
作者
Chewning, Rush H.
Murphy, Kieran J.
机构
[1] Johns Hopkins Univ, Sch Med, Div Intervent Neuroradiol, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
关键词
D O I
10.1016/j.jvir.2007.01.025
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Gadolinium-based contrast media are important tools in diagnostic and interventional radiology that are particularly useful in patients with renal insufficiency. Recent reports in which exposure to gadolinium compounds has been linked to the development of nephrogenic systemic fibrosis in this patient population, however, are quite concerning. It is of great importance that radiologists be aware of this serious disease and exercise caution when considering the use of gadolinium-based contrast media in patients with moderate (glomerular filtration rate, < 60 mL/min/1.73 m(2)) to severe (glomerular filtration rate, < 15 mL/min/1.73 m(2)) renal disease.
引用
收藏
页码:331 / 333
页数:3
相关论文
共 29 条
[1]   An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis [J].
Bartolini, ME ;
Pekar, J ;
Chettle, DR ;
McNeill, F ;
Scott, A ;
Sykes, J ;
Prato, FS ;
Moran, GR .
MAGNETIC RESONANCE IMAGING, 2003, 21 (05) :541-544
[2]   Gadolinium deposition in nephrogenic fibrosing dermopathy [J].
Boyd, Alan S. ;
Zic, John A. ;
Abraham, Jerrold L. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) :27-30
[3]   Nephrogenic systemic fibrosis: The nosological and conceptual evolution of nephrogenic fibrosing dermopathy [J].
Cowper, SE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (04) :763-765
[4]   Scleromyxoedema-like cutaneous diseases in renal-dialysis patients [J].
Cowper, SE ;
Robin, HS ;
Steinberg, SM ;
Su, LD ;
Gupta, S ;
LeBoit, PE .
LANCET, 2000, 356 (9234) :1000-1001
[5]   Nephrogenic fibrosing dermopathy: the first 6 years [J].
Cowper, SE .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (06) :785-790
[6]  
COWPER SE, 2001, NEPHROGENIC FIBROSIN
[7]  
DHARNIDHARKA VR, GADOLINIUM NEPHROGEN
[8]   The safety of gadolinium in patients with stage 3 and 4 renal failure [J].
Ergün, I ;
Keven, K ;
Uruç, I ;
Ekmekçi, Y ;
Canbakan, B ;
Erden, I ;
Karatan, O .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (03) :697-700
[9]   Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? [J].
Grobner, T .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (04) :1104-1108
[10]   Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis [J].
High, Whitney A. ;
Ayers, Reed A. ;
Chandler, John ;
Zito, Gary ;
Cowper, Shawn E. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) :21-26